Trophix: Mechanics of neuroscience

The application of molecular biology to neuroscience, as well as contributions from the Human Genome Project, have resulted in much progress in identifying genes and molecular mechanisms that can be targeted to treat neurological and psychiatric disorders. But addressing the complexity of the brain and its diseases is a tall order that still requires the evolution of rational therapies.

Trophix Pharmaceuticals Inc. has acquired a portfolio of genes that it hopes will lead to drug discovery

Read the full 755 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE